These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6320961

  • 1. Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites.
    Itzhak Y, Hiller JM, Gioannini TL, Simon EJ.
    Brain Res; 1984 Jan 23; 291(2):309-15. PubMed ID: 6320961
    [Abstract] [Full Text] [Related]

  • 2. ADP-ribosylation with pertussis toxin modulates the GTP-sensitive opioid ligand binding in digitonin-soluble extracts of rat brain membranes.
    Wong YH, Demoliou-Mason CD, Barnard EA.
    J Neurochem; 1988 Jul 23; 51(1):114-21. PubMed ID: 2837532
    [Abstract] [Full Text] [Related]

  • 3. Solubilization in high yield of opioid receptors retaining high-affinity delta, mu and kappa binding sites.
    Demoliou-Mason CD, Barnard EA.
    FEBS Lett; 1984 May 21; 170(2):378-82. PubMed ID: 6144572
    [Abstract] [Full Text] [Related]

  • 4. [Binding sites of opiates and endogenous opioids in the oocytes of the toad Bufo viridis].
    Bakalkin GIa, Iakovleva TV, Korobov KP, Bespalova ZhD, Vinogradov VA.
    Biokhimiia; 1984 Jun 21; 49(6):883-8. PubMed ID: 6087934
    [Abstract] [Full Text] [Related]

  • 5. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B, Puget A, Moisand C, Meunier JC.
    Eur J Pharmacol; 1990 Jul 31; 189(1):1-9. PubMed ID: 2171960
    [Abstract] [Full Text] [Related]

  • 6. Characterization of opioid receptor subtypes in solution.
    Demoliou-Mason CD, Barnard EA.
    J Neurochem; 1986 Apr 31; 46(4):1129-36. PubMed ID: 2869106
    [Abstract] [Full Text] [Related]

  • 7. Characterization and partial purification of solubilized active opiate receptors from toad brain.
    Ruegg UT, Cuenod S, Hiller JM, Gioannini T, Howells RD, Simon EJ.
    Proc Natl Acad Sci U S A; 1981 Jul 31; 78(7):4635-8. PubMed ID: 6270689
    [Abstract] [Full Text] [Related]

  • 8. Distinct molecular forms of opiate binding in the frog brain.
    Puget A, Jauzac P, Meunier JC.
    Life Sci; 1983 Jul 31; 33 Suppl 1():199-202. PubMed ID: 6319860
    [Abstract] [Full Text] [Related]

  • 9. 5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.
    Mollereau C, Pascaud A, Baillat G, Mazarguil H, Puget A, Meunier JC.
    J Biol Chem; 1988 Dec 05; 263(34):18003-8. PubMed ID: 2848020
    [Abstract] [Full Text] [Related]

  • 10. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T, Wüster M, Gramsch C, Herz A.
    Mol Pharmacol; 1985 Aug 05; 28(2):146-54. PubMed ID: 2991735
    [Abstract] [Full Text] [Related]

  • 11. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S, Pasternak GW.
    Brain Res; 1982 Sep 23; 248(1):192-5. PubMed ID: 6289993
    [Abstract] [Full Text] [Related]

  • 12. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF, Nishimura S, Goodman RR, Pasternak GW.
    J Pharmacol Exp Ther; 1985 Dec 23; 235(3):839-45. PubMed ID: 2416909
    [Abstract] [Full Text] [Related]

  • 13. [Stability of opiate receptors of wet and lyophilized preparations of rat brain membranes].
    Zaĭtsev SV, Kurochkin IN, Sergeeva MG, Varfolomeev SD.
    Biokhimiia; 1984 Jul 23; 49(7):1127-33. PubMed ID: 6089917
    [Abstract] [Full Text] [Related]

  • 14. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL, Brown SR, Puttfarcken P, Cox BM.
    Mol Pharmacol; 1986 Aug 23; 30(2):90-5. PubMed ID: 3016504
    [Abstract] [Full Text] [Related]

  • 15. Evidence for disulfide bonds in membrane-bound and solubilized opioid receptors.
    Kamikubo K, Murase H, Murayama M, Matsuda M, Miura K.
    J Neurochem; 1988 Feb 23; 50(2):503-9. PubMed ID: 2826698
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM.
    Mol Pharmacol; 1986 Aug 23; 30(2):81-9. PubMed ID: 3016503
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB, Bowen WD, Herkenham M, Jacobson AE, Rice KC, Pert CB.
    Mol Pharmacol; 1985 Mar 23; 27(3):399-409. PubMed ID: 2579319
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.